Vassalli JD - Search Results

1

An inhibitor of serine proteases, neuroserpin, acts as a neuroprotective agent in a mouse model of neurodegenerative disease.

Simonin Y, Charron Y, Sonderegger P, Vassalli JD, Kato AC. Simonin Y, et al. Among authors: vassalli jd. J Neurosci. 2006 Oct 11;26(41):10614-9. doi: 10.1523/JNEUROSCI.3582-06.2006. J Neurosci. 2006. PMID: 17035547 Free PMC article.

2

Expression of serpinb6 serpins in germ and somatic cells of mouse gonads.

Charron Y, Madani R, Nef S, Combepine C, Govin J, Khochbin S, Vassalli JD. Charron Y, et al. Among authors: vassalli jd. Mol Reprod Dev. 2006 Jan;73(1):9-19. doi: 10.1002/mrd.20385. Mol Reprod Dev. 2006. PMID: 16175637

3

Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression.

Bolon I, Zhou HM, Charron Y, Wohlwend A, Vassalli JD. Bolon I, et al. Among authors: vassalli jd. Am J Pathol. 2004 Jun;164(6):2299-304. doi: 10.1016/S0002-9440(10)63786-8. Am J Pathol. 2004. PMID: 15161662 Free PMC article.

4

The serpin Spn5 is essential for wing expansion in Drosophila melanogaster.

Charron Y, Madani R, Combepine C, Gajdosik V, Hwu Y, Margaritondo G, Vassalli JD. Charron Y, et al. Among authors: vassalli jd. Int J Dev Biol. 2008;52(7):933-42. doi: 10.1387/ijdb.072419yc. Int J Dev Biol. 2008. PMID: 18956323 Free article.

5

Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis.

Pepper MS, Montesano R, Mandriota SJ, Orci L, Vassalli JD. Pepper MS, et al. Among authors: vassalli jd. Enzyme Protein. 1996;49(1-3):138-62. doi: 10.1159/000468622. Enzyme Protein. 1996. PMID: 8797003 Review.

6

Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases.

Montesano R, Pepper MS, Belin D, Vassalli JD, Orci L. Montesano R, et al. Among authors: vassalli jd. J Cell Physiol. 1988 Mar;134(3):460-6. doi: 10.1002/jcp.1041340318. J Cell Physiol. 1988. PMID: 2450879

7

Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice.

Madani R, Hulo S, Toni N, Madani H, Steimer T, Muller D, Vassalli JD. Madani R, et al. Among authors: vassalli jd. EMBO J. 1999 Jun 1;18(11):3007-12. doi: 10.1093/emboj/18.11.3007. EMBO J. 1999. PMID: 10357813 Free PMC article.

8

Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.

Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD. Zhou HM, et al. Among authors: vassalli jd. Cancer Res. 2001 Feb 1;61(3):970-6. Cancer Res. 2001. PMID: 11221892

9

Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis.

Moll S, Menoud PA, Fulpius T, Pastore Y, Takahashi S, Fossati L, Vassalli JD, Sappino AP, Schifferli JA, Izui S. Moll S, et al. Among authors: vassalli jd. Kidney Int. 1995 Nov;48(5):1459-68. doi: 10.1038/ki.1995.435. Kidney Int. 1995. PMID: 8544402 Free article.

10

Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.

Barazzone C, Belin D, Piguet PF, Vassalli JD, Sappino AP. Barazzone C, et al. Among authors: vassalli jd. J Clin Invest. 1996 Dec 15;98(12):2666-73. doi: 10.1172/JCI119089. J Clin Invest. 1996. PMID: 8981909 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters